Position history for Capital International Investors's holdings in CRISPR THERAPEUTICS AG
Capital International Investors holds 1.2M shares of CRSP (CRISPR THERAPEUTICS AG), worth $56.5M as of 2026-Q1. The position was decreased (-79.9% shares). CRSP represents 0.0% of Capital International Investors's portfolio.
Current Value
$56.5M
Current Shares
1.2M
Total Value Change
-$368.3M
Total Shares Change
-6.7M
Other major holders of CRSP: ARK Investment Management LLC
Decreased |
| 1.2M |
-79.9% |
| $56.5M |
| 0.0% |
| $58.06 |
0 |
| 2025-Q4 | Increased | 5.9M | +4.3% | $309M | 0.0% | $53.19 | 32 |
| 2025-Q3 | Increased | 5.6M | +1.0% | $366.1M | 0.1% | $63.77 | 31 |
| 2025-Q2 | Decreased | 5.6M | -7.9% | $272.1M | 0.0% | $47.49 | 0 |
| 2025-Q1 | Decreased | 6.1M | -30.5% | $206.7M | 0.0% | $36.99 | 0 |
| 2024-Q4 | Increased | 8.7M | +10.3% | $344.1M | 0.1% | $38.65 | 34 |
| 2024-Q3 | Increased | 7.9M | +0.8% | $372.4M | 0.1% | $47.32 | 31 |
| 2024-Q2 | Increased | 7.9M | +0.4% | $424.8M | 0.1% | $54.01 | 31 |